ASHM COVID-19 taskforce on HIV, Viral Hepatitis, and Sexual health

 

UPDATED ON: 16 September 2021.

ASHM’s Taskforce on BBVs, Sexual Health and COVID-19 was established on 20 March 2020. It provides a timely opportunity for the BBV and sexual health sectors to discuss the scientific, clinical, BBV and sexual health service delivery and social implications of COVID-19, and provides consistent and evidence-based messaging to the health workforce, sector partners and community.

Below you can find the various outputs of the taskforce, information about its structure and membership and links to ASHM and external resources in the context of COVID-19. If you want to provide feedback or have any questions regarding the Taskforce please email taskforce@ashm.org.au.

 

Latest guidance from the Taskforce & Regional Advisory Group

19 September 2021

Regional Advisory Group

Principles regarding the Prioritisation of COVID-19 vaccines for People Living with HIV and their service providers

5 August 2021

FAQs for clinicians about covid-19 vaccines and people living with Hepatitis B/Hepatitis C-related chronic liver disease

5 August 2021

FAQs for clinicians about covid-19 vaccines and people living with HIV
ASHM COVID-19 Taskforce interim recommendations 

11 March 2021

Statement from the ASHM COVID-19 Taskforce regarding the Prioritisation of COVID-19 Vaccines for People Living with Blood-borne virus-related Chronic Liver Disease

 Conference 

Devils in the Details – Making sense of COVID-19 

10 September 2021

covid day

Download the Executive Summary 

For a deeper dive, download the conference report

If you missed the conference, you can still register and view the sessions

 

 

 

 

Most accessed

#1 FAQs for clinicians about covid-19 vaccines and people living with HIV
ASHM COVID-19 Taskforce interim recommendations 

#2 Statement from the ASHM COVID-19 Taskforce regarding the Prioritisation of COVID-19 Vaccines for People Living with HIV

#3 Statement from the ASHM COVID-19 Taskforce regarding the Prioritisation of COVID-19 Vaccines for People Living with Blood-borne virus-related Chronic Liver Disease


The following is a list of current Taskforce members. This list is continually updated as participation grows.

This document shows the four topic areas of the Taskforce work and the Cluster Groups within each topic. The Taskforce have been allocated to both the topics and the Cluster Groups that reflect their expertise. The document is updated regularly as participation increases.

Support ASHM

some 1 text

some 2 text

some other 3 text

some 1 text

some 2 text

some other 3 text

 

 


 

 

 

General